Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes

Guofang Hou(Tianjin Medical University Cancer Institute and Hospital), Sheng Zhang(Tianjin Medical University Cancer Institute and Hospital), Xiaobei Zhang(Ministry of Education of the People's Republic of China), Pei Wang(Ministry of Education of the People's Republic of China), Xiaomeng Hao(Ministry of Education of the People's Republic of China), Jin Zhang(Tianjin Medical University Cancer Institute and Hospital)
Breast Cancer Research and Treatment
January 5, 2013
10.1007/s10549-012-2404-y
Cited by 94

Abstract

Related Papers

New Users of Metformin Are at Low Risk of Incident Cancer
Gillian Libby, Louise A. Donnelly, Peter T. Donnan et al.|Diabetes Care|2009|985
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
Evandro de Azambuja, Fátima Cardoso, Gilberto de Castro et al.|British Journal of Cancer|2007|958
Metformin Inhibits Mammalian Target of Rapamycin–Dependent Translation Initiation in Breast Cancer Cells
Ryan J.O. Dowling, Mahvash Zakikhani, I. George Fantus et al.|Cancer Research|2007|927
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus
Bethany B Barone|JAMA|2008|894
Insulin Signaling in Health and Disease
Morris F. White|Science|2003|725